JP2016520585A5 - - Google Patents

Download PDF

Info

Publication number
JP2016520585A5
JP2016520585A5 JP2016512879A JP2016512879A JP2016520585A5 JP 2016520585 A5 JP2016520585 A5 JP 2016520585A5 JP 2016512879 A JP2016512879 A JP 2016512879A JP 2016512879 A JP2016512879 A JP 2016512879A JP 2016520585 A5 JP2016520585 A5 JP 2016520585A5
Authority
JP
Japan
Prior art keywords
molecule according
collagen molecule
chondroitin sulfate
collagen
pxg
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016512879A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016520585A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/SG2014/000204 external-priority patent/WO2014182249A1/en
Publication of JP2016520585A publication Critical patent/JP2016520585A/ja
Publication of JP2016520585A5 publication Critical patent/JP2016520585A5/ja
Pending legal-status Critical Current

Links

JP2016512879A 2013-05-09 2014-05-09 修飾コラーゲン分子 Pending JP2016520585A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SG201303597-7 2013-05-09
SG2013035977 2013-05-09
PCT/SG2014/000204 WO2014182249A1 (en) 2013-05-09 2014-05-09 Modified collagen molecules

Publications (2)

Publication Number Publication Date
JP2016520585A JP2016520585A (ja) 2016-07-14
JP2016520585A5 true JP2016520585A5 (https=) 2017-06-15

Family

ID=51867585

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016512879A Pending JP2016520585A (ja) 2013-05-09 2014-05-09 修飾コラーゲン分子

Country Status (6)

Country Link
US (1) US20160075765A1 (https=)
EP (1) EP2994484A4 (https=)
JP (1) JP2016520585A (https=)
CN (1) CN105392799A (https=)
SG (1) SG11201509238WA (https=)
WO (1) WO2014182249A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3787702B1 (en) 2018-05-03 2024-08-07 CollPlant Ltd. Dermal fillers and applications thereof
CN116410302B (zh) * 2023-02-21 2025-09-12 汤臣倍健股份有限公司 一种富糖胺聚糖胶原蛋白肽的应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2672587B2 (ja) * 1988-08-23 1997-11-05 生化学工業株式会社 新規ix型コラーゲン、それを構成する新規超高分子コンドロイチン硫酸及びそれらの製造法
US5475052A (en) * 1988-11-21 1995-12-12 Collagen Corporation Collagen-synthetic polymer matrices prepared using a multiple step reaction
US5866165A (en) * 1997-01-15 1999-02-02 Orquest, Inc. Collagen-polysaccharide matrix for bone and cartilage repair
US6780841B2 (en) * 2001-11-13 2004-08-24 Biocell Technology, Llc Hyaluronic acid and chondroitin sulfate based hydrolyzed collagen type II and method of making same
US20060067959A1 (en) * 2004-09-28 2006-03-30 Marcel Nimni Compositions and methods for treatment of solar damage
WO2007044026A2 (en) * 2004-11-23 2007-04-19 The Johns Hopkins University Compositions comprising modified collagen and uses therefore
CA2695288A1 (en) * 2007-08-01 2009-02-05 Ethicon, Inc. Collagen-related peptides and uses thereof
US20090068250A1 (en) * 2007-09-07 2009-03-12 Philippe Gravagna Bioresorbable and biocompatible compounds for surgical use
US20120122791A1 (en) * 2009-05-01 2012-05-17 Jnc Corporation Substrate for cartilage cultivation using artificial collagen, and method for cartilage regeneration treatment using the substrate
HRP20170482T1 (hr) * 2011-05-24 2017-05-19 Symic Ip, Llc Sintetski peptidoglikani koji vežu hijaluronsku kiselinu, dobivanje, i postupci uporabe
WO2013023137A2 (en) * 2011-08-10 2013-02-14 William Marsh Rice University Multi-hierarchical self-assembly of a collagen mimetic peptide
JP6051619B2 (ja) * 2012-06-29 2016-12-27 Jnc株式会社 コラーゲン様ポリペプチドの製造方法

Similar Documents

Publication Publication Date Title
HK1206297A1 (en) Pharmaceutical compositions for combination therapy
WO2017132432A8 (en) Benzimidazole derivatives as modulators of ror-gamma
CY1122189T1 (el) Ιονικες υδατικες συνθεσεις
WO2017087608A8 (en) Modulators of ror-gamma
CY1117559T1 (el) Ενωση ινδολιου και φαρμακευτικη χρηση αυτου
BRPI0912411B8 (pt) uso de uma muteína de interleucina humana-2 (muteína de hil-2) e composição farmacêutica para o tratamento e/ou profilaxia de uma doença autoimune
CY1119880T1 (el) Παραγωγα πυρρολοπυριμιδινης για χρηση στη θεραπεια ιικων λοιμωξεων
EP2540284A3 (en) Compositions and methods for stabilized polysaccaride formulations
CY1117326T1 (el) Παραγωγο κατεχολαμινης χρησιμο για τη θεραπεια ασθενειας parkinson
BRPI0915084A2 (pt) composto, processo para a preparação de um composto, composição farmacêutica, uso de um composto, métodos para a profilaxia ou tratamento de um estado de doença ou uma condição e de câncer
FI2034956T4 (fi) Matalan viskositeetin omaavia glykosaminoglykaaneja käsittäviä koostumuksia ja mainitun koostumuksen käyttö kroonisen kystiitin terapiassa
UA111588C2 (uk) Композиція інгібітора jak для місцевого застосування
MX2009008531A (es) Cetonas de heterociclilo que contienen nitrogeno y su uso como inhibidores de c-met.
EA201690904A1 (ru) Антибактериальная композиция для ротовой полости
CY1118947T1 (el) Ασυμμετρες ουριες και ιατρικες χρησεις αυτων
EA201391486A1 (ru) Способы и композиции для лечения болезни паркинсона
MX363923B (es) Composicion de farmaco de carbohidrato novedoso para el tratamiento de enfermedades humanas.
MY149505A (en) Hyaluronic acid binary mixtures and therapeutic use thereof
EP3059254A3 (en) A sulphated polysaccharide compound for the clinical use and the preparation and use thereof
CY1119431T1 (el) Τοπικη αντιμικροβιακη δερματολογικη συνθεση
WO2017062468A8 (en) Ppar agonists, compounds, pharmaceutical compositions, and methods of use thereof
CY1114735T1 (el) Θεραπευτικες συνθεσεις οι οποιες περιεχουν εναν ειδικο ανταγωνιστη του υποδοχεα της ενδοθηλινης και εναν αναστολεα της pde5
CY1117504T1 (el) Παραγωγα 1-βενζυλ-3-υδροξυμεθυλινδαζολης και η χρηση τους στη θεραπευτικη αντιμετωπιση νοσων που βασιζονται στην εκφραση των mcp-1, και cx3cr1
EP4342473A3 (en) Compounds useful in hiv therapy
ATE530188T1 (de) Zusammensetzungen und verfahren zur abgabe von mitteln gegen krebs